Mark Kotter

Company: bit.bio

Job title: Founder & Chief Executive Officer

Seminars:

Implementing Next-Generation Cellular Reprogramming for the Consistent & Scalable Production of Cells for Therapies 2:30 pm

Modulating cell characteristics and optimizing function for therapeutic application Making stem cells scalable with synthetic biologyRead more

day: Day One

Industry Leaders’ Fireside Chat: Designing & Constructing Biological Systems with Novel Functionalities to Produce More Efficient & Accessible Therapeutics 8:30 am

Reflecting on the evolution of synthetic biology over the past decade: what have we learned? Leveraging different therapeutic modalities (small molecules, mRNA, cell therapies, vaccines and more): what is next for synthetic biology? Exploring the challenges that lie ahead: how do we predict the future challengesRead more

day: Day One